Monday, March 10, 2025
spot_img

Danske Bank share buy-back programme: transactions in week 10

 

Company announcement no. 11 2025

Danske Bank

Bernstorffsgade 40

DK-1577 København V

Tel. + 45 33 44 00 00

10/03/2025

Page 1 of 1

Danske Bank share buy-back programme: transactions in week 10

On 7 February 2025, Danske Bank A/S announced a share buy-back programme for a total of DKK 5 billion, with a maximum of 45,000,000 shares, in the period from 10 February 2025 to 30 January 2026, at the latest, as described in company announcement no. 6 2025.

The Programme is carried out in accordance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and Council of 16 April 2014 (the “Market Abuse Regulation”) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”).

The following transactions on Nasdaq Copenhagen A/S were made under the share buy-back programme in week 10:

  Number of shares VWAP DKK Gross value DKK
Accumulated, last announcement 75,000 235.7421 17,680,656
03/03/2025 5,000 241.8573 1,209,287
04/03/2025 5,000 237.0313 1,185,157
05/03/2025 5,000 241.6338 1,208,169
06/03/2025 5,000 243.5822 1,217,911
07/03/2025 5,000 241.5688 1,207,844
Total accumulated over week 10 25,000 241.1347 6,028,367
Total accumulated during the share buyback programme 100,000 237.0902 23,709,023

With the transactions stated above, the total accumulated number of own shares under the share buy-back programme corresponds to 0.012% of Danske Bank A/S’ share capital.

Danske Bank

Contact: Claus Ingar Jensen, Head of Group Investor Relations, tel. +45 25 42 43 70

Attachment

  • Danske Bank Template Company announcement UK

Powered by SlickText.com

Hot this week

Correction: Final terms for bonds to be listed 11th March 2025: New final terms attached

To Nasdaq Copenhagen A/S                        10th March 2025                                        Announcement no. 22/2025Final terms...

First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy...

VIVOPOWER ACTIVATES AND EXTENDS STOCK BUYBACK PROGRAM OF UP TO US$5 MILLION (UPDATED)

Stock Buyback Program commencing from today, with broker engaged...

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) --...

Topics

Correction: Final terms for bonds to be listed 11th March 2025: New final terms attached

To Nasdaq Copenhagen A/S                        10th March 2025                                        Announcement no. 22/2025Final terms...

First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy...

VIVOPOWER ACTIVATES AND EXTENDS STOCK BUYBACK PROGRAM OF UP TO US$5 MILLION (UPDATED)

Stock Buyback Program commencing from today, with broker engaged...
spot_img

Related Articles

Popular Categories

spot_img